Skip to main content

Advertisement

SpringerLink
Log in

Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. A Collaborative Study of the Group Francais de Cytogenetique Hematologique (1996) Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings outcome. Blood 87(8):3135–3142

    Google Scholar 

  2. Tanguy-Schmidt A, Rousselot P, Chalandon Y, Cayuela JM, Hayette S, Vekemans MC, Escoffre M, Huguet F, Rea D, Delannoy A, Cahn JY, Vernant JP, Ifrah N, Dombret H, Thomas X (2012) Long-term follow-up of the Imatinib GRAAPH-2003 Study in newly diagnosed patients with de novo Philadelphia chromosome-positive acute lymphoblastic leukemia: a GRAALL study. Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation. doi:10.1016/j.bbmt.2012.08.021

  3. Snyder DS (2000) Allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Biol Blood Marrow Transplant: J American Soc Blood Marrow Transplant 6(6):597–603

    Article  CAS  Google Scholar 

  4. Caocci G, Vacca A, Ledda A, Murgia F, Piras E, Greco M, Arras M, Atzeni S, Littera R, La Nasa G (2012) Prophylactic and preemptive therapy with dasatinib after hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplantation 18(4):652–654. doi:10.1016/j.bbmt.2011.12.587

    Article  Google Scholar 

  5. Loken MR, Alonzo TA, Pardo L, Gerbing RB, Raimondi SC, Hirsch BA, Ho PA, Franklin J, Cooper TM, Gamis AS, Meshinchi S (2012) Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group. Blood 120(8):1581–1588. doi:10.1182/blood-2012-02-408336

    Article  PubMed  Google Scholar 

  6. Grigoriou EE, Psarra KK, Garofalaki MK, Tziotziou EC, Papasteriades CA (2012) BCR-ABL fusion protein detection in peripheral blood and bone marrow samples of adult precursor B-cell acute lymphoblastic leukemia patients using the flow cytometric immunobead assay. Clinical Chem Lab Med: CCLM / FESCC 50(9):1657–1663. doi:10.1515/cclm-2011-0686

    CAS  Google Scholar 

  7. Nakasone H, Kanda Y, Takasaki H, Nakaseko C, Sakura T, Fujisawa S, Yokota A, Yano S, Usuki K, Maruta A, Abe D, Hoshino T, Takahashi S, Kanamori H, Okamoto S (2010) Prophylactic impact of imatinib administration after allogeneic stem cell transplantation on the incidence and severity of chronic graft versus host disease in patients with Philadelphia chromosome-positive leukemia. Leukemia: J Leukemia Soc Am, Leukemia Research Fund, UK 24(6):1236–1239. doi:10.1038/leu.2010.83

    Article  CAS  Google Scholar 

  8. Yoshihara S, Ando T, Ogawa H (2012) Extramedullary relapse of acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation: an easily overlooked but significant pattern of relapse. Biol Blood Marrow Transplant: J Am Soc Blood Marrow Transplantation. doi:10.1016/j.bbmt.2012.05.010

  9. Rytting ME, Wierda WG (2004) Central nervous system relapse in two patients with chronic myelogenous leukemia in myeloid blastic phase on imatinib mesylate therapy. Leukemia Lymphoma 45(8):1623–1626. doi:10.1080/10428190410001667703

    Article  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest

Author information

Authors and Affiliations

  1. Division of Hematology/Oncology, Department of Medicine, Taichung Veterans General Hospital, 160, Section 3, Chungkang Road, Taichung, 407, Taiwan

    Chieh-Lin Jerry Teng, Jui-Ting Yu & Wen-Li Hwang

  2. Department of Life Science, Tunghai University, Taichung, Taiwan

    Chieh-Lin Jerry Teng

  3. Department of Medicine, Chung Shan Medical University, Taichung, Taiwan

    Chieh-Lin Jerry Teng

  4. Department of Radiology, Taichung Veterans General Hospital, Taichung, Taiwan

    Hung-Chieh Chen

Authors
  1. Chieh-Lin Jerry Teng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jui-Ting Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hung-Chieh Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Wen-Li Hwang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Wen-Li Hwang.

Additional information

Chieh-Lin Jerry Teng and Jui-Ting Yu contributed equally to this manuscript.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Teng, CL.J., Yu, JT., Chen, HC. et al. Maintenance therapy with dasatinib after allogeneic hematopoietic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia. Ann Hematol 92, 1137–1139 (2013). https://doi.org/10.1007/s00277-012-1670-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-012-1670-4

Keywords

Search

Navigation